InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Rabinowitz Michael, Responsable Commercial. Officer active across 1 companies, notably Oramed Pharmaceuticals INC.. In total, 6 disclosures have been published. The latest transaction was filed on 28 December 2021 — Retenue fiscale. Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
19,000 shares
Common Stock
SEC:0001213900-22-000814:0·
19,000 shares
Common Stock
SEC:0001213900-22-000814·
€109,2019,532 shares@ €11.4563100.0% of flow
Common Stock
SEC:0001213900-21-068230·
€109,2019,532 shares@ €11.45630.098% mcap50.0% of flow
Common Stock
SEC:0001213900-21-068230:0·
0100,000 shares0
Common Stock
SEC:0001213900-21-040761·
0100,000 shares0
Common Stock
SEC:0001213900-21-040761:0·
6 of 6 declarations
About Rabinowitz Michael
Michael Rabinowitz is the Chief Commercial Officer at ORAMED PHARMACEUTICALS INC. He is responsible for managing the company's sales and business development. His expertise in commercial strategy is essential to support growth and optimize financial results. Michael also plays a key role in establishing strategic partnerships and expanding into new markets.
